BioSpace.com

TRENTON, N.J. -- After 20 months running drugmaker Sanofi-Aventis SA, Chris Viehbacher wants to end the roller coaster of revenue peaks and valleys as blockbuster drugs climb to billions in sales and suddenly plummet when generic competition hits.

CHICAGO--(BUSINESS WIRE)--GTCR, one of the countrys leading private equity firms, announced today that Actient Pharmaceuticals, LLC has successfully completed a transaction to license and acquire six pharmaceutical products from UCB, Inc., a subsidiary of UCB SA, an international biopharmaceutical company based in Brussels, Belgium.

The acquisition of the six on-market products is the first...

WASHINGTON (Dow Jones)--The Senate Appropriations Committee on Thursday approved a measure that would restrict the use of controversial settlements in which brand-name drug companies pay their generic competitors to drop patent challenges that could lead to early entry of generic drugs.

SAN DIEGO, July 29 /PRNewswire-FirstCall/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) announced that results from its COR-I trial of Contrave were published online today in the journal Lancet. COR-I was the largest of the four, 56-week, Phase 3 trials supporting the New Drug Application for Contrave, currently under review by the U.S. Food and Drug Administration...

WASHINGTON July 29 (Reuters) - U.S. health officials warned Thursday about the risk of pneumonia with Cubist Pharmaceuticals Inc's (CBST.O) flagship antibiotic.

Business Week -- Anacor Pharmaceuticals said Thursday it will receive a $15 million payment from GlaxoSmithKline on a deal over a potential antibiotic.

Billings Gazette -- CODY A federal judge has denied a last-minute request by Wyomings only pharmaceutical manufacturer to block a pending enforcement action that appears likely to force the company to cease manufacturing a potent painkiller.

New Kerala -- Washington, July 29 : A new study has found that men, who develop prostate cancer, tend to retain denser bones as they age than men who stay free of the disease.

SHENZHEN, CHINA--(Marketwire - 07/29/10) - Hard to Treat Diseases, Inc. (Pinksheets:HTDS - News)(http://www.htdsmedical.com) announces the company's intention to sell current subsidiary Slavica Biochem to a US-based publicly traded biomedical company.

HTDS is pleased with the performance of Slavica, a Belgrade-based medical research centre that is currently evaluating various medications and...

TORONTO July 30 (Reuters) - Angiotech Pharmaceuticals Inc (ANP.TO) said its second-quarter loss widened on Friday as royalty payments from its marketing partners slowed.

MedPage Today -- Calcium supplementation appears to increase the risk of myocardial infarction, a meta-analysis showed.

ScienceDaily (July 29, 2010) UCLA scientists have identified for the first time a cell-of-origin for human prostate cancer, a discovery that could result in better predictive and diagnostics tools and the development of new and more effective targeted treatments for the disease.

Life Science World -- HOUSTON - Researchers have discovered an enzyme crucial to a type of DNA repair that also causes resistance to a class of cancer drugs most commonly used against ovarian cancer.

WILMINGTON, Mass., Jul 29, 2010 (BUSINESS WIRE) -- Charles River Laboratories International, Inc. /quotes/comstock/13*!crl/quotes/nls/crl (CRL 34.00, 2.05, 6.42%) , a leading global provider of research models and associated services and of preclinical drug development services, today announced that it has mutually agreed with WuXi PharmaTech (Cayman) Inc. /quotes/comstock/13*!wx/quotes/nls/wx ...

MELBOURNE July 29 (Reuters) - Australia's competition watchdog cleared Novartis AG's (NOVN.VX) planned buyout of Alcon Laboratories (ACL.N), after Novartis agreed to sell one of Alcon's products to eye care company Bausch & Lomb in Australia.

THURSDAY, July 29 (HealthDay News) -- Weight loss has been noted among patients who've had a knee or hip replacement, a new study says.

July 30, 2010 DNA India -- Carnegie Mellon researchers have come up with a new fluorescent biosensor that could aid in the development of an important class of drugs that target a crucial class of proteins called G protein-coupled receptors (GPCRs).

MENLO PARK, Calif., Jul 30, 2010 (BUSINESS WIRE) -- Geron Corporation /quotes/comstock/15*!gern/quotes/nls/gern (GERN 5.38, 0.58, 12.08%) announced today that the U.S. Food and Drug Administration (FDA) has notified the company that the clinical hold placed on Geron's Investigational New Drug (IND) application has been lifted and the company's Phase I clinical trial of GRNOPC1 in patients with...

EurekAlert! -- EAST LANSING, Mich. The apparently random self-assembly of molecular threads into the proteins that make the body work is far less frantic than previously thought, Michigan State University scientists say. That discovery could be a key to help unlock the nature of some diseases.

WASHINGTON (Reuters) - Sanofi-Aventis failed to follow proper manufacturing procedures at a vaccine plant in France, U.S. regulators said in a letter released on Thursday.